Pritika H. Shahani

Analysis of differential secondary effects of novel rexinoids: select rexinoid X receptor ligands demonstrate differentiated side effect profiles

Pamela A. Marshall, Peter W. Jurutka, Carl E. Wagner et al. · Pharmacology Research & Perspectives · 2015 · 25 citations · Full text

Modeling, Synthesis, and Biological Evaluation of Potential Retinoid X Receptor (RXR)-Selective Agonists: Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(5,5,8,8-tetrahydronaphthalen-2-yl)amino)nicotinic Acid (NEt-TMN)

Michael Heck, Carl E. Wagner, Pritika H. Shahani et al. · Journal of Medicinal Chemistry · 2016 · 20 citations · Full text

Testing Novel Pyrimidinyl Rexinoids: A New Paradigm for Evaluating Rexinoids for Cancer Prevention

Di Zhang, Ana S. Leal, Sarah Carapellucci et al. · Cancer Prevention Research · 2019 · 19 citations · Full text

Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models

Jezabel Rodríguez‐Blanco, April Salvador, Robert K. Suter et al. · Journal of Clinical Investigation · 2024 · 13 citations · Full text